How to Triage PAINS-Full Research

Assay and Drug Development Technologies

Volumn 14, Issue 3, 2016, Pages 168-174

  Dahlin, Jayme L ^a,b   Walters, Michael A ^c  

^a Department of Molecular Pharmacology and Experimental Therapeutics ^*  (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; PAN ASSAY INTERFERENCE COMPOUND; UNCLASSIFIED DRUG; ORGANIC COMPOUND;

ASSAY; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; EDITOR; EMERGENCY HEALTH SERVICE; HIGH THROUGHPUT SCREENING; HUMAN; MEDICINAL CHEMISTRY; PUBLICATION; READING; REVIEW; SCIENTIST; ARTIFACT; CHEMISTRY; DRUG DEVELOPMENT; PROCEDURES;

ARTIFACTS; CHEMISTRY, PHARMACEUTICAL; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MOLECULAR STRUCTURE; ORGANIC CHEMICALS;

EID: 84964826870     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2015.674     Document Type: Review

References (26)

1. Baell JB, Holloway GA: New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719-2740.
2. Baell J, Walters MA: Chemistry: chemical con artists foil drug discovery. Nature (London, UK) 2014;513:481-483.
3. Dahlin JL, Nissink JWM, Strasser JM, et al.: PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem 2015;58:2091-2113.
4. Devine SM, Mulcair MD, Debono CO, et al.: Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. J Med Chem 2015;58:1205-1214.
5. Redhead M, Satchell R, Morkunaite V, et al.: A combinatorial biophysical approach; FTSA and SPR for identifying small molecule ligands and PAINs. Anal Biochem 2015;479:63-73.
6. Jayatunga MKP, Thompson S, McKee TC, et al.: Inhibition of the HIF1a-p300 interaction by quinone-and indandione-mediated ejection of structural Zn(ll). Eur J Med Chem 2015;94:509-516.
7. Ingolfsson HI, Thakur P, Herald KF, et al.: Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chem Biol 2014;9:1788-1798.
8. Hollmann A, Castanho MARB, Lee B, Santos NC: Singlet oxygen effects on lipid membranes: implications for the mechanism of action of broad-spectrum viral fusion inhibitors. Biochem J 2014;459:161-170.
9. Baell JB: Observations on screening-based research and some concerning trends in the literature. Future Med Chem 2010;2:1529-1546.
10. Baell JB: Screening-based translation of public research encounters painful problems. ACS Med Chem Lett 2015;6:229-234.
11. Arrowsmith CH, Audia JE, Austin C, et al.: The promise and peril of chemical probes. Nat Chem Biol 2015;11:536-541.
12. Baell Jonathan B, Prisinzano TE, Erlanson DA: Avoiding PAINS (pan-assay interference compounds), www.acs.org/content/acs/en/acs-webinars/drug-discovery/pains.html (last accessed on May 28, 2015).
13. Lagorce D, Sperandio O, Miteva MA, Villoutreix BO, Baell JB: FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res 2015;43:W200-W207.
14. Saubern S, Guha R, Baell JB: KNIME workflow to assess PAINS filters in SMARTS format. Comparison of RDKit and indigo cheminformatics libraries. Mol Inf 2011;30:847-850.
15. Canny SA, Cruz Y, Southern MR, Griffin PR: PubChem promiscuity: a web resource for gathering compound promiscuity data from PubChem. Bioinformatics 2012;28:140-141.
16. Bologa C, Ursu O, Oprea T, Yang J: Badapple: Bioactivity data associative promiscuity pattern learning engine, http://pasilla.health.unm.edu/tomcat/badapple/badapple; See also: www.slideshare.net/jeremyjyang/badapple-bard-talk ACS National Meeting, Sept. 9, 2013, Indianapolis, IN (last accessed on 08-03-2015).
17. Yang JJ, Ursu 0, Bologa CG, Waller A, Sklar LA, Oprea TI: BADAPPLE promiscuity plugin for BARD: Evidence-based promiscuity scores. Abstracts of Papers, 246th ACS National Meeting & Exposition, Indianapolis, IN, September 8-12, 2013. American Chemical Society, 2013.
18. Howe EA, de SA, Lahr DL, et al.: BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types. Nucleic Acids Res 2015;43(Database issue):D1163-D1170.
19. Hu Y, Bajorath J: What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data. AAPS J 2013;15:808-815.
20. Ferreira RS, Simeonov A, Jadhav A, et al.: Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem 2010;53:4891-4905.
21. Shoichet BK: Screening in a spirit haunted world. Drug Discov Today 2006;11:607-615.
22. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL: Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007;6:29-40.
23. Dahlin JL, Inglese J, Walters MA: Mitigating risk in academic preclinical drug discovery. Nat Rev Drug Discov 2015;14:279-294.
24. Jurewicz A, Hofmann G, Carson J, et al.: Creation of a nuisance sample tool set for HTS assay design optimization. Paper presented at Society for Laboratory Automation and Screening, 2015, Washington, DC.
25. Dahlin JL, Walters MA: The essential roles of chemistry in high-throughput screening triage. Future Med Chem 2014;6:1265-1290.
26. Gilson MK, Georg G, Wang S: Digital chemistry in the journal of medicinal chemistry. J Med Chem 2014;57:1137.